Related references
Note: Only part of the references are listed.Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice
Kerstin Boengler et al.
CIRCULATION RESEARCH (2008)
Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction
Jian-Yong Qian et al.
HYPERTENSION (2008)
Prostaglandin E2 activates Stat3 in neonatal rat ventricular cardiomyocytes: A role in cardiac hypertrophy
Miguel A. Frias et al.
CARDIOVASCULAR RESEARCH (2007)
Doxorubicin-induccd cardiomyopathy from the cardiotoxic mechanisms to management
Genzou Takemura et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2007)
Disruption of COX-2 modulates gene expression and the cardiac injury response to doxorubicin
Tomas G. Neilan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Many good reasons to have STAT3 in the heart
D Hilfiker-Kleiner et al.
PHARMACOLOGY & THERAPEUTICS (2005)
STRESS signaling pathways that modulate cardiac myocyte apoptosis
CP Baines et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Oxidative stress-elicited myocardial apoptosis during reperfusion
ZQ Zhao
CURRENT OPINION IN PHARMACOLOGY (2004)
Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse
MC LaPointe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells
J Kluza et al.
ONCOGENE (2004)
Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning
RM Smith et al.
CARDIOVASCULAR RESEARCH (2004)
Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury
D Hilfiker-Kleiner et al.
CIRCULATION RESEARCH (2004)
Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure-with advanced age
JJ Jacoby et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mechanism of cyclooxygenase-2 upregulation in late preconditioning
YT Xuan et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2003)
Specificity and mechanism of action of some commonly used protein kinase inhibitors
SP Davies et al.
BIOCHEMICAL JOURNAL (2000)
Adriamycin-induced heart failure: mechanisms and modulation
P Singal et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2000)
Distinct mechanisms of STAT phosphorylation via the interferon-α/β receptor -: Selective inhibition of STAT3 and STAT5 by piceatannol
L Su et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Participation of prostaglandin E2 in the endothelial protective effect of ischaemic preconditioning in isolated rat heart
JF Bouchard et al.
CARDIOVASCULAR RESEARCH (2000)
Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy
K Kunisada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction
S Negoro et al.
CARDIOVASCULAR RESEARCH (2000)
Share Paper
